The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence

被引:30
作者
Premji, Zulfiqarali G. [1 ]
Abdulla, Salim [2 ]
Ogutu, Bernhards [3 ]
Ndong, Alice [4 ]
Falade, Catherine O. [5 ]
Sagara, Issaka [6 ]
Mulure, Nathan [7 ]
Nwaiwu, Obiyo [8 ]
Kokwaro, Gilbert [9 ,10 ]
机构
[1] Muhimbili Univ, Coll Hlth Sci, Sch Publ Hlth & Social Sci, Dept Parasitol Med Entomol, Dar Es Salaam, Tanzania
[2] Ifakara Hlth Res & Dev Ctr, Dar Es Salaam, Tanzania
[3] Kenya Govt Med Res Ctr, Clin Res Ctr, Kisumu, Kenya
[4] Ctr Nutr Educ & Res, Nairobi, Kenya
[5] Univ Coll Hosp, Dept Clin Pharmacol, Ibadan, Nigeria
[6] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali
[7] Novartis Pharma AG, Nairobi, Kenya
[8] Novartis Pharma AG, Lagos, Nigeria
[9] Kenya Govt Med Res Ctr, Wellcome Trust Programme, Nairobi, Kenya
[10] Univ Nairobi, Coll Hlth Sci, Dept Pharmaceut & Pharm Practice, Nairobi, Kenya
关键词
D O I
10.1186/1475-2875-7-244
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A fixed-dose combination of artemether-lumefantrine (AL, Coartem (R)) has shown high efficacy, good tolerability and cost-effectiveness in adults and children with uncomplicated malaria caused by Plasmodium falciparum. Lumefantrine bioavailability is enhanced by food, particularly As the fat content of sub-Saharan African meals is approximately a third that of Western countries, it raises the question of whether fat consumption by African patients is sufficient for good efficacy. Data from healthy volunteers have indicated that drinking 36 mL soya milk (containing only 1.2 g of fat) results in 90% of the lumefantrine absorption obtained with 500 mL milk (16 g fat). African diets are typically based on a carbohydrate staple (starchy root vegetables, fruit [plantain] or cereals) supplemented by soups, relishes and sauces derived from vegetables, pulses, nuts or fish. The most important sources of dietary fat in African countries are oil crops (e.g. peanuts, soya beans) and cooking oils as red palm, peanut, coconut and sesame oils. Total fat intake in the majority of subSaharan countries is estimated to be in the range 30-60 g/person/day across the whole population (average 43 g/person/day). Breast-feeding of infants up to two years of age is standard, with one study estimating a fat intake of 15-30 g fat/day from breast milk up to the age of 18 months. Weaning foods typically contain low levels of fat, and the transition from breast milk to complete weaning is associated with a marked reduction in dietary fat. Nevertheless, fat intake > 10 g/day has been reported in young children post-weaning. A randomized trial in Uganda reported no difference in the efficacy of AL between patients receiving supervised meals with a fixed fat content (similar to 23 g fat) or taking AL unsupervised, suggesting that fat intake at home was sufficient for optimal efficacy. Moreover, randomized trials in African children aged 5-59 months have shown similar high cure rates to those observed in older populations, indicating that food consumption is adequate post-weaning. In conclusion, it appears that only a very small amount of dietary fat is necessary to ensure optimal efficacy with AL and that the fat content of standard meals or breast milk in sub-Saharan Africa is adequate.
引用
收藏
页数:7
相关论文
共 31 条
  • [1] ABDULLA S, 2008, LANCET IN PRESS
  • [2] Ashley EA, 2007, TROP MED INT HEALTH, V12, P195, DOI [10.1111/j.1365-3165.2006.01784.x, 10.1111/j.1365-3156.2006.01784.x]
  • [3] A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
    Chanda, Pascalina
    Masiye, Felix
    Chitah, Bona M.
    Sipilanyambe, Naawa
    Hawela, Moonga
    Banda, Patrick
    Okorosobo, Tuoyo
    [J]. MALARIA JOURNAL, 2007, 6 (1)
  • [4] Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
    Checchi, Francesco
    Piola, Patrice
    Fogg, Carole
    Bajunirwe, Francis
    Biraro, Samuel
    Grandesso, Francesco
    Ruzagira, Eugene
    Babigumira, Joseph
    Kigozi, Isaac
    Kiguli, James
    Kyomuhendo, Juliet
    Ferradini, Laurent
    Taylor, Walter R. J.
    Guthmann, Jean-Paul
    [J]. MALARIA JOURNAL, 2006, 5 (1)
  • [5] Combination therapy for uncomplicated falciparum malaria in Ugandan children - A randomized trial
    Dorsey, Grant
    Staedke, Sarah
    Clark, Tamara D.
    Njama-Meya, Denise
    Nzarubara, Bridget
    Maiteki-Sebuguzi, Catherine
    Dokomajilar, Christian
    Kamya, Moses R.
    Rosenthal, Philip J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (20): : 2210 - 2219
  • [6] Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria
    Ezzet, F
    van Vugt, M
    Nosten, F
    Looareesuwan, S
    White, NJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 697 - 704
  • [7] Population pharmacokinetics and therapeutic response of CGP56697 (artemether plus benflumetol) in malaria patients
    Ezzet, F
    Mull, R
    Karbwang, J
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (06) : 553 - 561
  • [8] Efficacy and safety of artemether-lumefantrine (Coartem®) tablets (six-dose regimen) in African infants and children with acute) uncomplicated falcipaurum malaria
    Falade, C
    Makanga, M
    Premji, Z
    Ortmann, CE
    Stockmeyer, M
    de Palacios, PI
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2005, 99 (06) : 459 - 467
  • [9] A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda
    Fanello, C. I.
    Karema, C.
    van Doren, W.
    van Overmeir, Chantal
    Ngamije, D.
    D'Alessandro, U.
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2007, 101 (04) : 344 - 350
  • [10] *FAO CORP DOC RESP, AGR FOOD NUTR AFR RE, pCH7